Form D · Pharmaceuticals
Laguna Pharmaceuticals, Inc.
La Jolla, CA · CIK 0001609970
Offering snapshot reported Jul 30, 2015 · SEC filing
- Reported sold
- $4.48M Offering amount: $4.73M
- Investors reported
- 8 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Nov 15, 2011 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jul 30, 2015 | Initial | $4,475,606 | No comparison | 8 | SEC filing |
| Feb 17, 2015 | Initial | $16,576,124 | No comparison | 18 | SEC filing |
| Jun 12, 2014 | Initial | $1,000,000 | No comparison | 7 | SEC filing |
Offering details
- Securities
- Equity, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-244746
Source: Form D, filed Jul 30, 2015. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Robert Baltera, Jr. | Director, Executive |
| Arthur Brown | Director, Executive |
| Jerel Davis | Director |
| Howard Dittrich | Executive |
| Brian Farmer | Executive |
| Jim Graham | Director |
| Rajesh Khosla | Director, Executive |
| Kevin Lalande | Director |
| James Topper | Director |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
4225 Executive Square, Ste. 960
La Jolla, CA, 92037
La Jolla, CA, 92037